NCT03906799 - Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF) | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

March 19, 2019

Primary Completion Date

November 20, 2019

Study Completion Date

March 20, 2020

Conditions

Atrial Fibrillation

Interventions

DRUG

OMT-28

1 capsule given daily orally from Visit 3 (Day 1) to Visit 8 (Day 99 ± 3 days).

DRUG

Placebo

1 capsule given daily orally from Visit 3 (Day 1) to Visit 8 (Day 99 ± 3 days).

Trial Locations (25)

1023

Site 205, Budapest

1122

Site 201, Budapest

1527

Site 401, Sofia

4032

Site 203, Debrecen

6004

Site 404, Stara Zagora

6800

Site 206, Hódmezővásárhely

7624

Site 202, Pécs

8900

Site 204, Zalaegerszeg

9000

Site 402, Varna

10002

Site 111, Zhytomyr

18009

Site 102, Cherkasy

27401

Site 302, Slaný

28002

Site 301, Kolín

29000

Site 108, Khmelnytskyi

30460

Site 303, Pilsen

61018

Site 104, Kharkiv

61176

Site 107, Kharkiv

65025

Site 105, Odesa

76018

Site 110, Ivano-Frankivsk

88000

Site 103, Uzhhorod

02660

Site 113, Kiev

03038

Site 106, Kiev

03115

Site 101, Kiev

03680

Site 109, Kiev

04050

Site 112, Kiev